Iain McInnes, MD, PhD, discussed comparing bimekizumab and risankizumab for PsA.
Iain McInnes, MD, PhD
Advertisement
Director of the Institute of Infection, Immunity and Inflammation at the University of Glasgow, UK
Articles by Iain McInnes, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement